Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis

30 Nov 2024

Abstract excerpt

CXCL13 is a chemokine which is upregulated within the CNS in multiple sclerosis, Lyme neuroborreliosis, and other inflammatory diseases and is increasingly clinically useful as a biomarker. This review provides background for understanding its function in the immune system and its relationship to ectopic lymphoid follicles. Also reviewed are its utility in multiple sclerosis and Lyme neuroborreliosis and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Multiple Sclerosis Research Studies
Share to Toxin Mechanisms and Immunotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39766248
DOI: 10.3390/biom14121541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CXCL13 as a Biomarker: Background and Utility in Multiple SclerosisPMID 39766248Read ↗

Targeting CXCL13 During NeuroinflammationSemantic proximity Read ↗

The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosisSemantic proximity Read ↗

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisSemantic proximity Read ↗

Significant Role(s) of CXCL12 and the SDF-1 3'A Genetic Variant in the Pathogenesis of Multiple Sclerosis.Semantic proximity Read ↗

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman diseaseSemantic proximity Read ↗

Dysregulated lymphocyte localization in idiopathic multicentric Castleman diseaseSemantic proximity Read ↗

The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and diseaseSemantic proximity Read ↗

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.Semantic proximity Read ↗

Correlation of selected serum protein levels with the degree of disability and NEDA-3 status in multiple sclerosis phenotypes.Semantic proximity Read ↗

CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating DiseasesSemantic proximity Read ↗

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosisSemantic proximity Read ↗

Tertiary lymphoid organ neogenesis in grey matter pathology in multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.